BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15471765)

  • 1. Effects of generic-only drug coverage in a Medicare HMO.
    Christian-Herman J; Emons M; George D
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-455-68. PubMed ID: 15471765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study: hospitalizations increase when only generic drugs are used for Medicare Advantage members.
    Capitation Manag Rep; 2005 Mar; 12(3):30-2. PubMed ID: 15889631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population.
    Balkrishnan R; Byerly WG; Camacho FT; Shrestha A; Anderson RT
    Am J Manag Care; 2001 Nov; 7(11):1093-100. PubMed ID: 11725812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new Medicare drug benefit: much ado about little?
    Pauly MV
    LDI Issue Brief; 2004; 9(4):1-6. PubMed ID: 15035261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The provision of home health care services through health maintenance organizations.
    Parker M; Polich CL; Fischer LR; Pastor W; Krulewitch H; Pitt L; Olson P; Korn K
    Pride Inst J Long Term Home Health Care; 1989; 8(3):24-37. PubMed ID: 10303819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing the pharmacy benefit in Medicare HMOs: what do we really know?
    Lipton HL; Gross DJ; Stebbins MR; Syed LH
    Health Aff (Millwood); 2000; 19(2):42-58. PubMed ID: 10718021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in prescription drug use in HMO and self-insured health plans.
    Wallack SS; Thomas CP; Martin TC; Ryan A
    Med Care Res Rev; 2007 Feb; 64(1):98-116. PubMed ID: 17213460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare HMO exodus: system correction or prediction?
    Benjamin GC
    Physician Exec; 1999; 25(1):77-8. PubMed ID: 10387278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective strategies for managing pharmacy benefits.
    Jacobson D
    Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Employer-sponsored Medicare HMO strategies: common selection criteria.
    Paik JY
    Manag Care Q; 1997; 5(4):55-61. PubMed ID: 10175721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
    Fischer MA; Avorn J
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of Group Health Cooperative automated pharmacy data by drug benefit status.
    Boudreau DM; Doescher MP; Saver BG; Jackson JE; Fishman PA
    Pharmacoepidemiol Drug Saf; 2005 Dec; 14(12):877-84. PubMed ID: 15931653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taking a SCAN of social HMOs. Projects fill in the gaps left by Medicare.
    Ervin SL
    Health Prog; 1989 Jun; 70(5):40-4. PubMed ID: 10303553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bitter pill: the new Medicare prescription drug benefit.
    Siegel S
    Health Care Law Mon; 2005 Mar; ():3-9. PubMed ID: 15818780
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of generic-only drug benefits on seniors' medication use and financial burden.
    Tseng CW; Brook RH; Keeler E; Steers WN; Waitzfelder BE; Mangione CM
    Am J Manag Care; 2006 Sep; 12(9):525-32. PubMed ID: 16961441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of medicare health maintenance organizations on hospitalization rates for ambulatory care-sensitive conditions.
    Zeng F; O'Leary JF; Sloss EM; Lopez MS; Dhanani N; Melnick G
    Med Care; 2006 Oct; 44(10):900-7. PubMed ID: 17001260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductions in costly healthcare service utilization: findings from the Care Advocate Program.
    Shannon GR; Wilber KH; Allen D
    J Am Geriatr Soc; 2006 Jul; 54(7):1102-7. PubMed ID: 16866682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do HMOs reduce preventable hospitalizations for Medicare beneficiaries?
    Basu J; Mobley LR
    Med Care Res Rev; 2007 Oct; 64(5):544-67. PubMed ID: 17881621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.